LIVE

Serial Number

98695795

Owner

Elevar Therapeutics, Inc.

Attorney

Cynthia Johnson Walden

Filing Date

Aug 13, 2024

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

TULVEGIO RIVOCERANIB Trademark

Serial Number: 98695795

TULVEGIO RIVOCERANIB is a trademark filed by Elevar Therapeutics, Inc. on August 13, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Elevar Therapeutics, Inc. (3 trademarks)

1 Bridge Plaza N, Suite 850
Fort Lee, NJ 07024

Entity Type: 03

Legal Representation

Attorney of Record

Cynthia Johnson Walden

3,120 trademarks filed View all →

Correspondence Address

Cynthia Johnson Walden Fish & Richardson P.C.

P.O. Box 1022

Minneapolis, MN 55440-1022

United States

Trademark Details

Filing Date

August 13, 2024

Registration Date

Not Registered

Published for Opposition

July 8, 2025

Goods & Services

Development of therapeutics in the nature of pharmaceutical preparations for the treatment of cancer containing rivoceranib

Pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 14, 2026 EXRA

SOU EXTENSION 1 GRANTED

Feb 9, 2026 EX1G

SOU EXTENSION 1 FILED

Feb 9, 2026 EXT1

SOU TEAS EXTENSION RECEIVED

Feb 9, 2026 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 2, 2025 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 8, 2025 NPUB

PUBLISHED FOR OPPOSITION

Jul 8, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 2, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 2, 2025 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

May 8, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 8, 2025 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 8, 2025 TROA

NOTIFICATION OF PRIORITY ACTION E-MAILED

Mar 5, 2025 GPRN

PRIORITY ACTION E-MAILED

Mar 5, 2025 GPRA

PRIORITY ACTION WRITTEN

Mar 5, 2025 CPRA

ASSIGNED TO EXAMINER

Feb 26, 2025 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Feb 25, 2025 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 25, 2025 NWOS

NEW APPLICATION ENTERED

Aug 13, 2024 NWAP

Related Trademarks

More from this Owner

More in Same Class

Serial #98696197